Spectrum Pharmaceuticals
SPPI
SPPI was delisted on the 31st of July, 2023.
144 hedge funds and large institutions have $265M invested in Spectrum Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 60 increasing their positions, 45 reducing their positions, and 29 closing their positions.
143% more call options, than puts
Call options by funds: $632K | Put options by funds: $260K
34% more capital inflows, than outflows
Capital inflows: $37.1M | Capital outflows: $27.6M
33% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 45
1.89% more ownership
Funds ownership: 68.66% → 70.54% (+1.9%)
11% less funds holding
Funds holding: 161 → 144 (-17)
59% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock Fund Advisors
San Francisco,
California
|
+$8.53M |
| 2 |
Renaissance Technologies
New York
|
+$5.83M |
| 3 |
State Street
Boston,
Massachusetts
|
+$2.83M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.39M |
| 5 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
+$1.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$5.3M |
| 2 |
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$2.38M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.56M |
| 4 |
Secor Capital Advisors
New York
|
-$1.44M |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$1.35M |
SPPI Hedge Fund Activity: Q3 2016 in Review
144 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals (SPPI) for Q3 2016, worth a combined $265M — down 27% from $362M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of SPPI and 12 opened new positions — a net loss of 17 holders — while 45 trimmed existing stakes and 60 added.
The largest buyer was BlackRock Fund Advisors, adding an estimated $8.53M. The largest seller was Acadian Asset Management, cutting an estimated $5.3M.
- 144 institutional investors held Spectrum Pharmaceuticals (SPPI) as of Q3 2016, down from 161 in Q2 2016.
- Funds reported $265M of Spectrum Pharmaceuticals stock for Q3 2016, down 27% quarter-over-quarter.
- 12 funds opened new Spectrum Pharmaceuticals positions in Q3 2016 and 29 closed out, a net change of -17 holders.
- The largest Spectrum Pharmaceuticals buyer in Q3 2016 was BlackRock Fund Advisors, an estimated $8.53M added.
- The largest Spectrum Pharmaceuticals seller in Q3 2016 was Acadian Asset Management, an estimated $5.3M sold.
Based on aggregated 13F filings for Q3 2016.